���疫调节机制与信号 — Explained

By Editorial Desk · published 2025-08-14 · last reviewed 2025-09-20 · Data

Everything below concerns immunomodulatory peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2025-09-20. Where a claim depends on a specific study, the study is described rather than over-claimed.

免疫调节机制与信号

临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善，但临床终点获益在不同研究中并不一致。系统综述指出，研究间在人群、剂量和联合方案上差异较大，难以汇总结论。因此，Tα1的确切临床地位仍属开放问题，需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。

胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明，它可促进未成熟T细胞向成熟T细胞分化，并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子，从而更有效地呈递抗原。此外，自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体，而是调节宿主免疫应答的强度与方向。

在信号层面，Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示，它能激活髓样分化因子88依赖的通路，进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答，有助于细胞免疫。然而，具体受体和结合位点尚未完全确定，不同实验模型的结果存在差异。

Research History and Clinical Assessment

Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.

Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.

Thymosin-alpha-1 at a glance

Stability, Storage, and Analysis

Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.

Like most short peptides, thymosin alpha-1 is susceptible to hydrolysis under strongly acidic or basic conditions and to oxidation when exposed to air over long periods. The acetylated amino terminus blocks one common degradation route, which contributes to the molecule's relative robustness in solution. Lyophilized material generally retains potency for extended periods when kept cold and dry. Once reconstituted, aqueous solutions are less stable and are typically used within a defined window rather than held indefinitely at ambient temperature.

Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.

Related pages on this site

• Efficient overview
• Efficient primer
• Optimized review
• Lightweight analysis
• Quality summary
• Sustainable primer
• Connected reference
• Practical update

Molecular Structure and Biological Background

Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.

The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.

Handling, Storage, and Analysis

Lyophilized material is generally held at reduced temperature to slow degradation, and storage at minus twenty degrees Celsius or lower is common practice for long-term retention. Short-term working portions are often kept between two and eight degrees Celsius. Once dissolved, the peptide is less stable than the dry powder, and repeated freeze-thaw cycles are associated with loss of material and with aggregate formation. Vials are usually allowed to reach room temperature before opening so that condensation does not introduce moisture, and solutions are protected from light where practical.

Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography, which separates the peptide from closely related impurities and from truncated or oxidized variants. Mass spectrometry supplies the molecular mass and confirms the expected sequence length, while amino acid analysis can be used to check composition. Because the molecule has no chromophore beyond the peptide backbone, ultraviolet detection is typically performed at a low wavelength, where baseline interference from solvents and buffers is a practical concern. Water content and counter-ion content are often reported alongside purity.

Background, Structure, and Mechanism

Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.

Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.

Notes from published material

Inverse gas chromatography is a physical characterization analytical technique that is used in the analysis of the surfaces of solids. Inverse gas chromatography or IGC is a highly sensitive and versatile gas phase technique developed over 40 years ago to study the surface and bulk properties of particulate and fibrous materials. In IGC the roles of the stationary (solid) and mobile (gas or vapor) phases are inverted from traditional analytical gas chromatography (GC); IGC is considered a materials characterization technique (of the solid) rather than an analytical technique (of a gas mixture). In GC, a standard column is used to separate and characterize a mixture of several gases or vapors. In IGC, a single standard gas or vapor (probe molecule) is injected into a column packed with the solid sample under investigation. During an IGC experiment a pulse or constant concentration of a known gas or vapor (probe molecule) is injected down the column at a fixed carrier gas flow rate. The retention time of the probe molecule is then measured by traditional GC detectors (i.e. flame ionization detector or thermal conductivity detector). Measuring how the retention time changes as a function of probe molecule chemistry, probe molecule size, probe molecule concentration, column temperature, or carrier gas flow rate can elucidate a wide range of physico-chemical properties of the solid under investigation. Several in depth reviews of IGC have been published previously.

However, even these hydrocarbons became waterlogged and thick after two days of use. Gasoline does not absorb water from the atmosphere and is sometimes used if ethanol is not available. Ethanol is the most widely used coolant today, as American corn ethanol subsidies have made it less expensive than gasoline in many rural areas.

== Theory == Sir Geoffrey Ingram Taylor in 1964 described this phenomenon, theoretically derived based on general assumptions that the requirements to form a perfect cone under such conditions required a semi-vertical angle of 49.3° (a whole angle of 98.6°) and demonstrated that the shape of such a cone approached the theoretical shape just before jet formation. This angle is known as the Taylor angle. This angle is more precisely

Lily later attempts to bond with her father and tells him she loves him, but Eric is distracted when he receives blackmail revealing that the prostitute is underage and that their encounter was recorded. Eric subsequently dissolves his partnership with Harper to protect her from the potential scandal and leaves London. Ken Leung, who plays Eric, revealed in an interview that the crew filmed a since-deleted scene between Eric and his family for the episode "Dear Henry", where he lashes out at Lily for wearing a nose ring (as it reminds him of Harper) before regretting his outburst and leaving to buy cigarettes. Leung noted that the scene immediately preceded the episode's closing shot depicting Eric walking down an empty street as the credits roll.

== Origin and history == S. affinis originates from central and northern China. It had been cultivated in China by the 13th century. Before S. affinis was introduced to Europe, a related crop named S. palustris was collected in nature to be consumed as a vegetable. Later on the Germanic peoples used S. recta, another relative of S. affinis, as a medicinal plant. The plant was then cultivated from the 18th century onwards. In 1882 the crop was cultivated on a farm for the first time in Crosne. S. affinis is the only labiate which is cultivated as vegetable in Europe. At the beginning of the 20th century S. affinis became more and more popular until it was abandoned again in the 1970s due to problems with viruses and the plant's strong vagility (tendency to spread). Since 1990 there has been a rise in the cultivation of S. affinis with availability in some markets and grocery stores. The plant is listed in the "Handbook of Alien Species in Europe" as an invasive plant in Europe.

Sources: en.wikipedia.org

Further detail

Often the analyte displays a reversible CV wave (such as that depicted in Figure 1), which is observed when all of the initial analyte can be recovered after a forward and reverse scan cycle. Although such reversible couples are simpler to analyze, they contain less information than more complex waveforms. The waveform of even reversible couples is complex owing to the combined effects of polarization and diffusion. The difference between the two peak potentials (Ep), ΔEp, is of particular interest.

Biomolecular structure Mammalian Motif Finder MochiView Multiple EM for Motif Elicitation Nucleic acid sequence Protein primary structure Protein I-sites Sequence logo Sequence mining Structural motif Short linear motif Conserved sequence Protein domain

Following Enoch Powell's Rivers of Blood speech Heseltine publicly urged Heath to deal firmly with him—to the consternation of many in his local party at Tavistock, where Powell enjoyed strong support. Three days later, Heseltine was one of around two dozen Conservative MPs who defied the whip to abstain rather than vote against the second reading of the 1968 Race Relations Bill (which banned racial discrimination). He argued that the Conservatives should state their own alternative policy rather than just oppose. Heseltine was promoted to principal opposition spokesman on transport in November 1969, although unlike his predecessors Thatcher and Walker, he was not a member of the Shadow Cabinet. He went on a six-week tour of India, Hong Kong, Singapore, Australia and the US to study how their docks were run, in readiness for Labour's planned 1970 Docks Bill (which in the event was cancelled because of that year's general election).

Dithiothreitol (DTT) is an organosulfur compound with the formula (CH(OH)CH2SH)2. A colorless compound, it is classified as a dithiol and a diol. DTT is redox reagent also known as Cleland's reagent, after W. Wallace Cleland. The reagent is commonly used in its racemic form. Its name derives from the four-carbon sugar, threose. DTT has an epimeric ('sister') compound, dithioerythritol (DTE).

More recent publications have defined the usually recommended doses as 50 mg DMT and 100 mg harmaline orally. Besides DMT with harmaline, the properties and effects of oral DMT in combination with harmine have also been studied by Jonathan Ott. He found that the threshold dose was 20 or 30 mg DMT and 120 mg harmine orally. Shulgin also reported in TiHKAL that 35 to 40 mg DMT and 140 to 190 mg harmine were unmistakably active, whereas smaller doses of 30 mg DMT and 120 to 140 mg harmine orally were inactive. In notable contrast to harmaline, harmine does not have its own psychoactive effects when used at doses of up to at least 300 mg orally. In pharmahuasca, the harmala alkaloid is usually taken first and then DMT is taken 15 to 20 minutes later, although a shorter or longer interval may also be employed. The onset of oral DMT with an MAOI is within 1 hour and its duration is 4 to 6 hours.

Sources: en.wikipedia.org

Supporting material

=== 1996 === 8 September The Mystery of the Cocaine Mummies, about pre-Columbian transoceanic contact theories; German toxicologist Svetlana Balabanova made a discovery in a Munich museum; Svetlana, of the Institute of Forensic Science in Ulm, had invented tests for substances in hair and sweat; people did not believe her; toxicologist John Henry of Guy's Hospital; Egyptologist Ann Rosalie David made independent tests at Manchester Museum; Alfred Grimm of the Egyptian Museum in Munich - Staatliche Sammlung für Ägyptische Kunst; Karnak in Egypt; a French TF1 broadcast in 1981; Michelle Lescot of the National Museum of Natural History, France; Nasri Iskander, chief curator of the Egyptian Museum in Cairo; botanist Sandy Knapp of the Natural History Museum, London; John Baines (Egyptologist); anthropologist Alice Beck Kehoe of Marquette University, and early transatlantic ocean crossings; Martin Bernal of Cornell University. Narrated by Robin Ellis, produced by Hilary Lawson, directed by Sarah Marris, made by TVF 15 September The Great Leveller, about psychosomatic medicine, and how work affects our health, and research on health equity carried out by Richard G.

The diverse range of intrinsic activities of cyclotides also continues to hold promise for a wide range of applications in the agricultural fields against insects and nematodes, especially those from Clitoria ternatea.

Salvinorin A is not scheduled at the federal level in the United States. Its molecular structure is unlike any Schedule I or II drug, so possession or sales is unlikely to be prosecuted under the Federal Analogue Act.

== Research == 1999: Preliminary results of early clinical trials with the fully human anti-TNF monoclonal antibody D2E7. 2001, June: Results from ARMADA, a double-blind, placebo-controlled clinical trial involving 271 patients with active rheumatoid arthritis, despite treatment with methotrexate, are announced. Results show that 50% of patients demonstrate a 50% improvement in their American College of Rheumatology (ACR) score. 2002: Broke ground on a new biologics manufacturing facility. 2002: Adalimumab results from five separate trials show that it is effective at reducing signs and symptoms of rheumatoid arthritis, with rapid onset of action and sustained efficacy. Adalimumab was safe and effective when given alone or in combination with methotrexate (MTX) as a subcutaneous injection. 2002: Humira approved by the US Food and Drug Administration (FDA) for treatment of rheumatoid arthritis. 2003: Humira made available for the treatment of rheumatoid arthritis and continued clinical studies for additional indications. 2005: Humira made available for the treatment of psoriatic arthritis. Exceeded US$1 billion in annual sales for the first time. 2005: Japanese company Eisai submits new drug application to make adalimumab (D2E7) available for the treatment of rheumatoid arthritis in Japan. 2006: Submitted Humira for approval for the treatment of Crohn's disease. Approved for the treatment of ankylosing spondylitis. Exceeded US$2 billion in annual sales. 2007: Humira approved for the treatment of Crohn's disease in the United States.

Sources: en.wikipedia.org

Frequently asked questions